T. Rowe Price Associates
TCDA

T. Rowe Price Associates’s Tricida, Inc. Common Stock TCDA Stock Holding History

T. Rowe Price Associates’s Portfolio TCDA Stock Details TCDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-192,353
Closed -$1.86M – 3071
2022
Q2 		$1.86M Buy
+192,353
New +$1.83M ﹤0.01% 1641
2021
Q1 		– Sell
-1,158,637
Closed -$8.17M – 2882
2020
Q4 		$8.17M Sell
1,158,637
-124,374
-10% -$954K ﹤0.01% 1377
2020
Q3 		$11.6M Sell
1,283,011
-2,422,151
-65% -$35.4M ﹤0.01% 1263
2020
Q2 		$102M Buy
3,705,162
+214,899
+6% +$5.85M 0.01% 634
2020
Q1 		$76.8M Sell
3,490,263
-938,955
-21% -$30.1M 0.01% 652
2019
Q4 		$167M Buy
4,429,218
+298,472
+7% +$11.1M 0.02% 517
2019
Q3 		$128M Buy
4,130,746
+229,421
+6% +$7.69M 0.02% 550
2019
Q2 		$154M Buy
3,901,325
+1,603,231
+70% +$56.4M 0.02% 523
2019
Q1 		$88.8M Buy
2,298,094
+1,180,255
+106% +$27.5M 0.01% 673
2018
Q4 		$26.4M Buy
1,117,839
+116,058
+12% +$3.34M ﹤0.01% 1058
2018
Q3 		$30.6M Sell
1,001,781
-1,119
-0.1% -$32.8K ﹤0.01% 1085
2018
Q2 		$30M Buy
+1,002,900
New +$28M ﹤0.01% 1067

Other funds holding TCDA

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
SCM
Stonehill Capital Management New York $350M AUM 73.6% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

T. Rowe Price Associates's TCDA Position: Q3 2022 in Review

T. Rowe Price Associates sold out of Tricida, Inc. Common Stock (TCDA) in Q3 2022, closing a stake of 192,353 shares — an estimated $1.86M sold.

T. Rowe Price Associates first reported a position in TCDA in Q2 2018 and held it in 12 quarters. The position peaked at $167M in Q4 2019. 120 funds tracked by Wall St. Rank hold TCDA as of Q3 2022.

  • T. Rowe Price Associates reported no remaining Tricida, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • T. Rowe Price Associates sold 192,353 Tricida, Inc. Common Stock shares in Q3 2022, an estimated $1.86M.
  • T. Rowe Price Associates first reported a position in Tricida, Inc. Common Stock in Q2 2018 and held it in 12 quarters.
  • T. Rowe Price Associates's Tricida, Inc. Common Stock position peaked at $167M in Q4 2019.
  • 120 funds tracked by Wall St. Rank held Tricida, Inc. Common Stock as of Q3 2022.

Based on T. Rowe Price Associates's 13F filing for Q3 2022, filed 14 Nov 2022.